Sweden and Boston-based biopharmaceutical development company Aprea AB has named Christian S. Schade as president and CEO. Previously, Schade was CEO of Novira Therapeutics. Aprea's backers include Versant Ventures, 5AM Ventures, Sectoral Asset Management and HealthCap.
Falfurrias hires Great Hill’s Greg Stewart to help lead tech, services deals
3 November 2026 · 1 min read
EIV’s Kristin Kelly: From aspiring vet to energy investor
3 November 2026 · 5 mins read
Permira hires former S&P Global CEO Douglas Peterson as senior adviser
2 November 2026 · 2 mins read
o15 Capital Partners hires Capital One’s Rochelle Probst as managing director
29 October 2026 · 1 min read
HighPost Capital hires Quail Ridge founder Ron Sylvestri as managing director, marketing
28 October 2026 · 1 min read
Broad Sky Partners hires ex-Partners Group investor Henry Elefter as managing director
28 October 2026 · 2 mins read
HarbourVest names ex-Hamilton Lane executive Peter Larsen head of infrastructure distribution
27 October 2026 · 1 min read
